Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15785814rdf:typepubmed:Citationlld:pubmed
pubmed-article:15785814lifeskim:mentionsumls-concept:C0030498lld:lifeskim
pubmed-article:15785814lifeskim:mentionsumls-concept:C0003374lld:lifeskim
pubmed-article:15785814lifeskim:mentionsumls-concept:C0050795lld:lifeskim
pubmed-article:15785814lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:15785814lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:15785814lifeskim:mentionsumls-concept:C0678226lld:lifeskim
pubmed-article:15785814lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:15785814lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:15785814lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:15785814lifeskim:mentionsumls-concept:C1527240lld:lifeskim
pubmed-article:15785814lifeskim:mentionsumls-concept:C1722992lld:lifeskim
pubmed-article:15785814pubmed:issue7lld:pubmed
pubmed-article:15785814pubmed:dateCreated2005-3-23lld:pubmed
pubmed-article:15785814pubmed:abstractText5'-methylenearisteromycin 5 and its 2-fluoro derivative 6, which were designed as antimalarial agents because of their AdoHcy hydrolase inhibition, were synthesized from D-ribose, using a stereoselective intramolecular radical cyclization as the key step to construct the carbocyclic structure. These compounds were evaluated as AdoHcy hydrolase inhibitors with the recombinant human and malarial parasite enzymes. Although 5 and 6 were both potent inhibitors of the malarial parasite AdoHcy hydrolase, the 2-fluoro derivative 6 proved to be superior due to its lower inhibitory effect on the human enzyme. In addition, 6 was identified as a potent antimalarial agent using an in vitro assay system with Plasmodium falciparum.lld:pubmed
pubmed-article:15785814pubmed:languageenglld:pubmed
pubmed-article:15785814pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15785814pubmed:citationSubsetIMlld:pubmed
pubmed-article:15785814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15785814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15785814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15785814pubmed:statusMEDLINElld:pubmed
pubmed-article:15785814pubmed:monthAprlld:pubmed
pubmed-article:15785814pubmed:issn1477-0520lld:pubmed
pubmed-article:15785814pubmed:authorpubmed-author:MatsudaAkiraAlld:pubmed
pubmed-article:15785814pubmed:authorpubmed-author:TakagiChiekoClld:pubmed
pubmed-article:15785814pubmed:authorpubmed-author:ShutoSatoshiSlld:pubmed
pubmed-article:15785814pubmed:authorpubmed-author:KimHye-SookHSlld:pubmed
pubmed-article:15785814pubmed:authorpubmed-author:WatayaYusukeYlld:pubmed
pubmed-article:15785814pubmed:authorpubmed-author:KitadeYukioYlld:pubmed
pubmed-article:15785814pubmed:authorpubmed-author:SukedaMakotoMlld:pubmed
pubmed-article:15785814pubmed:authorpubmed-author:YabeSaoriSlld:pubmed
pubmed-article:15785814pubmed:issnTypePrintlld:pubmed
pubmed-article:15785814pubmed:day7lld:pubmed
pubmed-article:15785814pubmed:volume3lld:pubmed
pubmed-article:15785814pubmed:ownerNLMlld:pubmed
pubmed-article:15785814pubmed:authorsCompleteYlld:pubmed
pubmed-article:15785814pubmed:pagination1245-51lld:pubmed
pubmed-article:15785814pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15785814pubmed:meshHeadingpubmed-meshheading:15785814...lld:pubmed
pubmed-article:15785814pubmed:meshHeadingpubmed-meshheading:15785814...lld:pubmed
pubmed-article:15785814pubmed:meshHeadingpubmed-meshheading:15785814...lld:pubmed
pubmed-article:15785814pubmed:meshHeadingpubmed-meshheading:15785814...lld:pubmed
pubmed-article:15785814pubmed:meshHeadingpubmed-meshheading:15785814...lld:pubmed
pubmed-article:15785814pubmed:meshHeadingpubmed-meshheading:15785814...lld:pubmed
pubmed-article:15785814pubmed:meshHeadingpubmed-meshheading:15785814...lld:pubmed
pubmed-article:15785814pubmed:meshHeadingpubmed-meshheading:15785814...lld:pubmed
pubmed-article:15785814pubmed:meshHeadingpubmed-meshheading:15785814...lld:pubmed
pubmed-article:15785814pubmed:year2005lld:pubmed
pubmed-article:15785814pubmed:articleTitleSynthesis of 5'-methylenearisteromycin and its 2-fluoro derivative with potent antimalarial activity due to inhibition of the parasite S-adenosylhomocysteine hydrolase.lld:pubmed
pubmed-article:15785814pubmed:affiliationGraduate School of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo, 060-0812, Japan.lld:pubmed
pubmed-article:15785814pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15785814pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed